S.AnanthaswamyH
I had a big issue that was complicated, and she stayed on the phone and sorted each one to a positive resolution." Trustpilot review, January 2026 Quality Concerns: Compounded medications are NOT FDA-approved
Lipase supplementation in particular may help with fat digestion, reducing the undigested fat that can cause osmotic diarrhea
GLP-1 (Glucagon-like Peptide-1) is a natural incretin hormone that: Stimulates insulin secretion (when glucose is high) Suppresses glucagon release Slows gastric emptying Increases satiety reducing food intake Why GLP-1 Therapy Stands Out Glycemic Control Lowers HbA1c by ~11.5% with minimal hypoglycemia risk Weight Loss 515 kg depending on drug/dose (semaglutide leads the way) Cardiovascular Protection Reduced major CV events (MACE) in trials like LEADER, SUSTAIN, REWIND Renal Protection Slows progression of diabetic kidney disease Convenience Available as daily or weekly injections and even oral semaglutide Key Clinical Trials LEADER (Liraglutide) CV mortality & MACE SUSTAIN-6 (Semaglutide) CV events & strong weight loss REWIND (Dulaglutide) CV protection even in lower-risk populations STEP Trials (Semaglutide) Double-digit weight reduction in obesity The Bigger Picture GLP-1 therapy goes beyond insulin and beyond diabetes
If symptoms persist or worsen, the Wegovy SmPC advises that temporary dose reduction or pausing dose escalation may be considered in consultation with a healthcare professional
Kosower NS, Zipser Y, Faltin Z
